Importance of MUC1 and spontaneous mouse tumor models for understanding the immunobiology of human adenocarcinomas

被引:33
|
作者
Finn, Olivera J. [1 ]
Gantt, Kira R. [1 ]
Lepisto, Andrew J. [1 ]
Pejawar-Gaddy, Sharmila [1 ]
Xue, Jia [1 ]
Beatty, Pamela L. [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA
关键词
Lung cancer; Pancreatic cancer; Cancer vaccine; Tumor-associated antigens; Mucin; CARCINOMA-ASSOCIATED ANTIGEN; BETA-CATENIN; C-SRC; CANCER; GROWTH; CELLS; TRANSCRIPTION; PROTEIN; IMMUNITY; STRESS;
D O I
10.1007/s12026-011-8214-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Many important aspects of cancer biology, such as cancer initiation, progression, and metastasis, have been studied in animal models, mostly mice. As long as cancer was considered primarily a genetic disease, the study of transplantable mouse tumors, or even human tumor xenografts in immunocompromised mice, appeared to suffice. Many important genetic events that lead to transformation and in vivo tumor growth were elucidated. However, many even more important factors that determine whether or not the genetic potential of a tumor cell will be realized, such as the host response to the tumor and the tumor microenvironment that influences this response over a long period of time of tumor development, remained untested and unappreciated. This is slowly changing with the advent of molecular techniques that have spurred efforts to engineer better mouse models of human tumors. In this review, we show results of our efforts to combine a genetic mouse model of spontaneous human adenocarcinomas based on a Kras mutation, with an important human molecule MUC1 that is abnormally expressed on human adenocarcinomas, promoting oncogenesis, proinflammatory tumor microenvironment, and immunosurveillance.
引用
收藏
页码:261 / 268
页数:8
相关论文
共 50 条
  • [1] Importance of MUC1 and spontaneous mouse tumor models for understanding the immunobiology of human adenocarcinomas
    Olivera J. Finn
    Kira R. Gantt
    Andrew J. Lepisto
    Sharmila Pejawar-Gaddy
    Jia Xue
    Pamela L. Beatty
    Immunologic Research, 2011, 50 : 261 - 268
  • [2] MUC1 and the Immunobiology of Cancer
    Joyce Taylor-Papadimitriou
    Joy M. Burchell
    Timothy Plunkett
    Rosalind Graham
    Isabel Correa
    David Miles
    Michael Smith
    Journal of Mammary Gland Biology and Neoplasia, 2002, 7 : 209 - 221
  • [3] MUC1 and the immunobiology of cancer
    Taylor-Papadimitriou, J
    Burchell, JM
    Plunkett, T
    Graham, R
    Correa, I
    Miles, D
    Smith, M
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2002, 7 (02) : 209 - 221
  • [4] MUC1 as a human tumor marker
    Imai, K
    Hayashi, T
    Suwa, T
    Makiguchi, Y
    Itoh, F
    Hinoda, Y
    Takahashi, T
    NEW DEVELOPMENTS IN GLYCOMEDICINE, 2001, 1223 : 125 - 133
  • [5] MUC1 Immunobiology in Transgenic Preclinical Models for Endometriosis and Endometrioid Ovarian Cancer
    Budiu, Raluca A.
    Mantia-Smaldone, Gina M.
    Brozick, Joan
    Edwards, Robert P.
    Vlad, Anda M.
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (09) : 987 - 987
  • [6] Expression of Human MUC1 During Early Pregnancy in the Human MUC1 Transgenic Mouse Model
    Dharmaraj, Neeraja
    Gendler, Sandra J.
    Carson, Daniel D.
    BIOLOGY OF REPRODUCTION, 2009, 81 (06) : 1182 - 1188
  • [7] MUC1 immunobiology: From discovery to clinical applications
    Vlad, AM
    Kettel, JC
    Alajez, NM
    Carlos, CA
    Finn, OJ
    ADVANCES IN IMMUNOLOGY, VOL 82, 2004, 82 : 249 - 293
  • [8] MUC1 expression in acinar prostatic adenocarcinomas
    Dhir, R
    Parwani, AV
    Acquafondata, M
    Lourdaraj, L
    MODERN PATHOLOGY, 2005, 18 : 136A - 137A
  • [9] MUC1 expression in acinar prostatic adenocarcinomas
    Dhir, R
    Parwani, AV
    Lourdaraj, L
    LABORATORY INVESTIGATION, 2005, 85 : 136A - 137A
  • [10] Immunization with a Synthetic Human MUC1 Glycopeptide Vaccine against Tumor-Associated MUC1 Breaks Tolerance in Human MUC1 Transgenic Mice
    Stergiou, Natascha
    Glaffig, Markus
    Jonuleit, Helmut
    Schmitt, Edgar
    Kunz, Horst
    CHEMMEDCHEM, 2017, 12 (17) : 1424 - 1428